Login / Signup

Atrial Fibrillation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.

Ellen K ChangDayana ChansonJennifer Berano TehAleksi IukuridzeKelly PengStephen J FormanRyotaro NakamuraF Lennie WongLiYing CaiSaro H Armenian
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
The burden of AF after allogeneic HCT population is substantial, and the development of AF is associated with poor survival. We identified important associations between patient demographics, pre-HCT cardiac parameters, HCT-related exposures, and risk of AF, setting the stage for targeted prevention strategies during and after HCT.
Keyphrases